Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 0.6 -7.07%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Lineage Cell Therapeutics Accounts Receivables 2011-2024 | LCTX

Annual Accounts Receivables Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
745 K 297 K 50.6 M - - 51 K 139 K 344 K 754 K 549 K 576 K 404 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
50.6 M 51 K 5.45 M

Quarterly Accounts Receivables Lineage Cell Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
405 K 235 K 77 K 745 K 432 K 406 K 173 K 297 K 435 K 532 K 323 K 50.6 M 2.12 M - - 242 K 242 K - - 44 K - - - 51 K - - - 139 K - - - 344 K - - - 754 K 664 K 545 K 606 K 549 K 549 K 549 K 549 K 576 K 576 K 576 K 576 K 395 K 395 K 395 K 395 K 353 K 353 K 353 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
50.6 M 44 K 1.78 M